Compare ETFs and analyze holdings overlap
Search and add ETFs. Minimum 2 for comparison.
| ETF | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception |
|---|---|---|---|---|---|---|---|---|---|
| CACE | — | — | — | — | — | — | — | — | — |
| MEDX | 6.67% | 3.65% | 1.31% | 1.31% | 15.15% | — | — | — | 10.55% (Apr 2025) |
Last six full-calendar years
| ETF | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| CACE | — | — | — | — | — | — |
| MEDX | — | — | — | — | — | — |
TWR = Time-Weighted Return (measures fund performance). MWRR = Money-Weighted Return (measures your personal return including contribution timing). Past performance does not guarantee future results.
Latest reported top holdings for each ETF
| # | Holding | Weight |
|---|---|---|
| 1 | Royal Bank of Canada | 6.44% |
| 2 | The Toronto-Dominion Bank | 5.23% |
| 3 | Canadian Natural Resources Ltd | 2.9% |
| 4 | Suncor Energy Inc | 2.85% |
| 5 | Canadian Imperial Bank of Commerce | 2.73% |
| 6 | Bank of Nova Scotia | 2.61% |
| 7 | Agnico Eagle Mines Ltd | 2.61% |
| 8 | Bank of Montreal | 2.53% |
| 9 | Enbridge Inc | 2.43% |
| 10 | Barrick Mining Corp | 2.12% |
| # | Holding | Weight |
|---|---|---|
| 1 | Novo Nordisk A/S - ADR | 6.17% |
| 2 | Eli Lilly and Co | 5.97% |
| 3 | Merck & Co Inc | 5.42% |
| 4 | Vertex Pharmaceuticals Inc | 5.12% |
| 5 | Thermo Fisher Scientific Inc | 5.09% |
| 6 | Pfizer Inc | 5.06% |
| 7 | Johnson & Johnson | 5.03% |
| 8 | ROCHE HOLDING AG | 5.02% |
| 9 | Novartis AG | 5.0% |
| 10 | AstraZeneca PLC | 4.99% |
Our in-depth Canadian investing course covers ETFs, TFSAs, RRSPs, and building a portfolio you can stick with.